| Tiffany Carolyn Alexander, MD | |
|
1316 E 7th St, Auburn, IN 46706-2538 | |
| (260) 925-4600 | |
| Not Available |
| Full Name | Tiffany Carolyn Alexander |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1316 E 7th St, Auburn, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508183476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD0000049505 (Tennessee) | Secondary |
| 207P00000X | Emergency Medicine | 01084184A (Indiana) | Primary |
| Entity Name | Professional Emergency Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144215096 PECOS PAC ID: 2769384213 Enrollment ID: O20040123000999 |
News Archive
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
A training tool that helps physicians involve patients in decision-making can reduce the use of antibiotics for acute respiratory infections, according to a study published in CMAJ (Canadian Medical Association Journal).
Nutritional recommendations for the management of sarcopenia - also described as age-related muscle and functional loss - were published this past week in the clinical publication, Journal of American Medical Directors Association.
Despite the fact that the COVID-19 pandemic has been raging for over four months the world over, the incubation period has not been reliably estimated. A new study published on the preprint server medRxiv reviews the various attempts made so far to arrive at a more accurate estimate.
› Verified 9 days ago
| Entity Name | Community Hospital Of Lagrange County, Inc. |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1679674956 PECOS PAC ID: 1355382706 Enrollment ID: O20140318000136 |
News Archive
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
A training tool that helps physicians involve patients in decision-making can reduce the use of antibiotics for acute respiratory infections, according to a study published in CMAJ (Canadian Medical Association Journal).
Nutritional recommendations for the management of sarcopenia - also described as age-related muscle and functional loss - were published this past week in the clinical publication, Journal of American Medical Directors Association.
Despite the fact that the COVID-19 pandemic has been raging for over four months the world over, the incubation period has not been reliably estimated. A new study published on the preprint server medRxiv reviews the various attempts made so far to arrive at a more accurate estimate.
› Verified 9 days ago
| Entity Name | Parkview Wabash Hospital Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1245259878 PECOS PAC ID: 0244553360 Enrollment ID: O20141222002050 |
News Archive
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
A training tool that helps physicians involve patients in decision-making can reduce the use of antibiotics for acute respiratory infections, according to a study published in CMAJ (Canadian Medical Association Journal).
Nutritional recommendations for the management of sarcopenia - also described as age-related muscle and functional loss - were published this past week in the clinical publication, Journal of American Medical Directors Association.
Despite the fact that the COVID-19 pandemic has been raging for over four months the world over, the incubation period has not been reliably estimated. A new study published on the preprint server medRxiv reviews the various attempts made so far to arrive at a more accurate estimate.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tiffany Carolyn Alexander, MD 606 S Lake St, Hamilton, IN 46742-9678 Ph: (765) 546-7208 | Tiffany Carolyn Alexander, MD 1316 E 7th St, Auburn, IN 46706-2538 Ph: (260) 925-4600 |
News Archive
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced that on September 15, 2011, the U.S. Food and Drug Administration advised CorMedix, that the Center for Drug Evaluation and Research has been assigned as the lead agency for the pre-market review of Neutrolin.
A targeted gene silencing strategy blocks production of the dysfunctional huntingtin (Htt) protein, the cause of Huntington's disease, a fatal, inherited neurodegenerative disorder.
A training tool that helps physicians involve patients in decision-making can reduce the use of antibiotics for acute respiratory infections, according to a study published in CMAJ (Canadian Medical Association Journal).
Nutritional recommendations for the management of sarcopenia - also described as age-related muscle and functional loss - were published this past week in the clinical publication, Journal of American Medical Directors Association.
Despite the fact that the COVID-19 pandemic has been raging for over four months the world over, the incubation period has not been reliably estimated. A new study published on the preprint server medRxiv reviews the various attempts made so far to arrive at a more accurate estimate.
› Verified 9 days ago
Keith R Schreffler Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 | |
Ajiru S Nyambwa, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 Fax: 260-482-4442 | |
John D Wagel, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 | |
James Lebamoff, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1316 E 7th St, Auburn, IN 46706 Phone: 260-925-4600 |